We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-12.91%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$131B
AUM Growth
-$19.5B
Cap. Flow
+$2.76B
Cap. Flow %
2.11%
Top 10 Hldgs %
14.61%
Holding
3,199
New
67
Increased
1,772
Reduced
1,049
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$361M
2
CVS icon
CVS Health
CVS
+$180M
3
CI icon
Cigna
CI
+$158M
4
MSFT icon
Microsoft
MSFT
+$102M
5
AMZN icon
Amazon
AMZN
+$90M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 13.99%
3 Healthcare 13.63%
4 Industrials 10.39%
5 Consumer Discretionary 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KODK icon
3101
Kodak
KODK
$804M
$85K ﹤0.01%
33,200
AREX
3102
DELISTED
Approach Resources Inc.
AREX
$85K ﹤0.01%
96,530
HIL
3103
DELISTED
Hill International, Inc. Common Stock
HIL
$84K ﹤0.01%
+27,200
New +$86.7K
AMPE
3104
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$84K ﹤0.01%
704
+211
+43% +$32.4K
IMDZ
3105
DELISTED
Immune Design Corp.
IMDZ
$82K ﹤0.01%
62,943
AAC
3106
DELISTED
AAC Holdings
AAC
$81K ﹤0.01%
57,375
-1,064
-2% -$4.27K
NMTR
3107
DELISTED
9 Meters Biopharma
NMTR
$80K ﹤0.01%
1,725
NYMX
3108
DELISTED
Nymox Pharmaceutical Corp
NYMX
$80K ﹤0.01%
60,400
AKTS
3109
DELISTED
Akoustis Technologies Inc
AKTS
$76K ﹤0.01%
+15,190
New +$78K
LUMO
3110
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$75K ﹤0.01%
5,411
DNTH icon
3111
Dianthus Therapeutics
DNTH
$5.91B
$74K ﹤0.01%
+810
New +$110K
ECOR icon
3112
electroCore
ECOR
$55.3M
$72K ﹤0.01%
763
SNNA
3113
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$71K ﹤0.01%
30,497
-5,000
-14% -$44.1K
CTIC
3114
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$71K ﹤0.01%
95,500
GNE icon
3115
Genie Energy
GNE
$369M
$67K ﹤0.01%
+11,050
New +$69.3K
FSNN
3116
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
$66K ﹤0.01%
38,900
IMH
3117
DELISTED
Impac Mortgage Holdings Inc.
IMH
$66K ﹤0.01%
17,322
-6,236
-26% -$30.6K
PFIE
3118
DELISTED
Profire Energy, Inc
PFIE
$64K ﹤0.01%
44,000
MARK
3119
DELISTED
Remark Holdings, Inc.
MARK
$62K ﹤0.01%
5,090
BDSI
3120
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$62K ﹤0.01%
16,652
PRPL icon
3121
Purple Innovation
PRPL
$34.2M
$61K ﹤0.01%
412
NTGN
3122
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$61K ﹤0.01%
11,980
CFRX
3123
DELISTED
ContraFect Corporation
CFRX
$60K ﹤0.01%
+49
New +$77.7K
VERI icon
3124
Veritone
VERI
$96.7M
$59K ﹤0.01%
15,300
SER icon
3125
Serina Therapeutics
SER
$31.5M
$59K ﹤0.01%
+552
New +$70.2K

Similar funds

Charles Schwab's Q4 2018 Portfolio in Review

As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
  • Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
  • Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
  • Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
  • Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
  • Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
  • Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.

Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.